Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

March 3 (Reuters) - The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making ...

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. | In the letters sent to 30 different telehealth companies that market compounded versions of ...

Especially in women’s health, this former regulatory gray area could help patients who have waited too long for FDA-approved ...

The Food and Drug Administration’s crackdown on cheaper, independently produced versions of popular weight-loss and diabetes medications stoked anger and pushback from users, sellers and the Alliance ...

Add Yahoo as a preferred source to see more of our stories on Google. Wegovy and other injectable weight-loss medications have soared in popularity in the past two years. Supply issues and spotty ...

The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular weight-loss drugs like Ozempic and Zepbound.

The FDA has issued 30 warning letters to telehealth companies over misleading claims about compounded GLP-1 drugs. Regulators say some companies im ...

Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these medications and your GLP-1 dose, she added. Also, seek ongoing guidance on diet and ...

The FDA has issued 30 warning letters to telehealth companies for making false or misleading claims about compounded GLP-1 products on their websites. The letters cite violations including claims ...

The Cost of Weight Loss Drugs With and Without Insurance Key takeaways: Weight loss drugs can cost $200 to $2,000 monthly, depending on the medication. The ...